Phase II clinical benefit of everolimus in patients with recurrent endometrial carcinoma Sep. 29, 2009
Blocking RANK-L activity with ALX-0141, a potential treatment for bone resorption disorders Sep. 29, 2009
Shionogi and GSK report data from phase II trials of HIV integrase inhibitor S/GSK-1349572 Sep. 28, 2009
RSS